BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 27601363)

  • 1. Pretreatment Prognostic Nutritional Index Is an Independent Predictor of Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Targeted Therapy.
    Kwon WA; Kim S; Kim SH; Joung JY; Seo HK; Lee KH; Chung J
    Clin Genitourin Cancer; 2017 Feb; 15(1):100-111. PubMed ID: 27601363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of preoperative prognostic nutrition index as prognostic predictors in patients with metastatic renal cell carcinoma with tyrosine kinase inhibitors as first-line target therapy.
    Cai W; Zhong H; Kong W; Dong B; Chen Y; Zhou L; Xue W; Huang Y; Zhang J; Huang J
    Int Urol Nephrol; 2017 Nov; 49(11):1955-1963. PubMed ID: 28889323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilizing pre-therapy clinical schema and initial CT changes to predict progression-free survival in patients with metastatic renal cell carcinoma on VEGF-targeted therapy: a preliminary analysis.
    Smith AD; Shah SN; Rini BI; Lieber ML; Remer EM
    Urol Oncol; 2013 Oct; 31(7):1283-91. PubMed ID: 21956044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretreatment Serum Prealbumin as an Independent Prognostic Indicator in Patients With Metastatic Renal Cell Carcinoma Using Tyrosine Kinase Inhibitors as First-Line Target Therapy.
    Cai W; Kong W; Dong B; Zhang J; Chen Y; Xue W; Huang Y; Zhou L; Huang J
    Clin Genitourin Cancer; 2017 Jun; 15(3):e437-e446. PubMed ID: 28188047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of post-treatment hypoalbuminemia and survival in Chinese patients with metastatic renal cell carcinoma.
    Cai W; Zhang J; Chen Y; Kong W; Huang Y; Huang J; Zhou L
    Chin J Cancer; 2017 May; 36(1):47. PubMed ID: 28521783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The preoperative prognostic nutritional index is an independent predictor of survival in patients with renal cell carcinoma.
    Hofbauer SL; Pantuck AJ; de Martino M; Lucca I; Haitel A; Shariat SF; Belldegrun AS; Klatte T
    Urol Oncol; 2015 Feb; 33(2):68.e1-7. PubMed ID: 25240758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective study of predictive factors for unexpectedly prolonged or shortened progression-free survival and overall survival among patients with metastatic renal cell carcinoma who received first-line targeted therapy.
    Kim SH; Kim S; Joo J; Seo HK; Joung JY; Lee KH; Chung J
    BMC Cancer; 2016 Aug; 16():577. PubMed ID: 27484254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progression free survival of first line vascular endothelial growth factor-targeted therapy is an important prognostic parameter in patients with metastatic renal cell carcinoma.
    Seidel C; Busch J; Weikert S; Steffens S; Fenner M; Ganser A; Grünwald V
    Eur J Cancer; 2012 May; 48(7):1023-30. PubMed ID: 22436979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretreatment Lymphocyte to Monocyte Ratio is an Independent Prognostic Factor in Metastatic Clear Cell Renal Cell Carcinoma.
    Gu L; Ma X; Xie Y; Li H; Wang L; Chen L; Zhao W; Zhang Y; Zhang X
    Clin Genitourin Cancer; 2017 Jun; 15(3):e369-e377. PubMed ID: 28038932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognostic factors for metastatic renal cell carcinoma treated with second-line targeted therapies].
    Rebibo JD; Pfister C; Giwerc A; Defortescu G; Gouerant S; Di Fiore F; Nouhaud FX
    Prog Urol; 2016 Jan; 26(1):16-23. PubMed ID: 26455779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative Prognostic Nutritional Index is a Significant Predictor of Survival in Renal Cell Carcinoma Patients Undergoing Nephrectomy.
    Jeon HG; Choi DK; Sung HH; Jeong BC; Seo SI; Jeon SS; Choi HY; Lee HM
    Ann Surg Oncol; 2016 Jan; 23(1):321-7. PubMed ID: 26045392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skeletal muscle density predicts prognosis in patients with metastatic renal cell carcinoma treated with targeted therapies.
    Antoun S; Lanoy E; Iacovelli R; Albiges-Sauvin L; Loriot Y; Merad-Taoufik M; Fizazi K; di Palma M; Baracos VE; Escudier B
    Cancer; 2013 Sep; 119(18):3377-84. PubMed ID: 23801109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors Influencing Overall Survival for Patients With Metastatic Clear-Cell Renal-Cell Carcinoma in Daily Practice.
    Thiery-Vuillemin A; Cholley T; Calcagno F; Hugues M; Maurina T; Limat S; Nguyen Tan Hon T; Almotlak H; Mouillet G; Nerich V
    Clin Genitourin Cancer; 2018 Apr; 16(2):e297-e305. PubMed ID: 29066073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour burden is an independent prognostic factor in metastatic renal cell carcinoma.
    Iacovelli R; Lanoy E; Albiges L; Escudier B
    BJU Int; 2012 Dec; 110(11):1747-53. PubMed ID: 23106948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of prognostic nutritional index in renal cell carcinomas.
    Tang Y; Liang J; Liu Z; Zhang R; Zou Z; Wu K; Lu Y; Wei X
    Medicine (Baltimore); 2021 Mar; 100(10):e25127. PubMed ID: 33725913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic nutritional index predicts initial response to treatment and prognosis in metastatic castration-resistant prostate cancer patients treated with abiraterone.
    Fan L; Wang X; Chi C; Wang Y; Cai W; Shao X; Xu F; Pan J; Zhu Y; Shangguan X; Xin Z; Hu J; Xie S; Wang R; Zhou L; Dong B; Xue W
    Prostate; 2017 Sep; 77(12):1233-1241. PubMed ID: 28752926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretreatment neutrophil-to-lymphocyte ratio predicts prognosis in patients with metastatic renal cell carcinoma receiving targeted therapy.
    Zhang GM; Zhu Y; Gu WJ; Zhang HL; Shi GH; Ye DW
    Int J Clin Oncol; 2016 Apr; 21(2):373-378. PubMed ID: 26335242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Significance of Pre- to Postoperative Dynamics of the Prognostic Nutritional Index for Patients with Renal Cell Carcinoma Who Underwent Radical Nephrectomy.
    Kang M; Chang CT; Sung HH; Jeon HG; Jeong BC; Seo SI; Jeon SS; Choi HY; Lee HM
    Ann Surg Oncol; 2017 Dec; 24(13):4067-4075. PubMed ID: 28975525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of the MSKCC and Heng risk criteria models for predicting survival in patients with metastatic renal cell carcinoma treated with sunitinib.
    Kwon WA; Cho IC; Yu A; Nam BH; Joung JY; Seo HK; Lee KH; Chung J
    Ann Surg Oncol; 2013 Dec; 20(13):4397-404. PubMed ID: 24081805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Value of Inflammatory and Nutritional Scores in Renal Cell Carcinoma After Nephrectomy.
    Peng D; He ZS; Li XS; Tang Q; Zhang L; Yang KW; Yu XT; Zhang CJ; Zhou LQ
    Clin Genitourin Cancer; 2017 Oct; 15(5):582-590. PubMed ID: 28528087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.